Rapid and long-lasting suppression of the ATF-2 transcription factor is a common response to neuronal injury

Molecular Brain Research

Volumn 62, Issue 2, 1998, Pages 158-166

  Martin Villalba, A ^a   Winter, Ch ^a   Brecht, S ^b   Buschmann, T ^a   Zimmermann, M ^a   Herdegen, T ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Axotomy; c Jun; Dorsal root ganglia; Injury; Ischemia; Rat

Indexed keywords

DOXORUBICIN; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NERVE TRANSECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; AXOTOMY; BRAIN INJURIES; BRAIN ISCHEMIA; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOXORUBICIN; FACIAL NERVE INJURIES; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; GENES, JUN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE CRUSH; NERVE TISSUE PROTEINS; NEURONS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0032570051     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00239-3     Document Type: Article

References (34)

1. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 7:1986;472-476.
2. Benbrook D.M., Jones N.C. Heterodimer formation between CREB and JUN proteins. Oncogene. 5:1990;295-302.
3. Benbrook D.M., Jones N.C. Different binding specificities and transactivation of variant CRE's by CREB complexes. Nucleic Acids Res. 20:1994;1463-1469.
4. De Cesare D., Vallone D., Caracciolo A., Sassone-Corsi P., Nerlov C., Verde P. Heterodimerization of c-Jun with ATF-2 and c-Fos in required for positive and negative regulation of the human urokinase enhancer. Oncogene. 11:1995;365-376.
5. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-jun activation domain. Cell. 76:1994;1025-1037.
6. Ferrer I., Blanco R., Rivera R., Carmona M., Ballabriga J., Olive M., Planas A.M. CREB-1 and CREB-2 immunoreactivity in the rat brain. Brain Res. 712:1996;159-164.
7. Gass P., Herdegen T. Expression of AP-1 proteins in excitotoxic-neurodegenerative disorders and following nerve fiber injury. Prog. Neurobiol. 47:1995;257-290.
8. Gass P., Herdegen T., Bravo R., Kiessling M. Spatiotemporal induction of immediate early genes in the rat brain after limbic seizures: effects of NMDA receptor antagonist MK-801. Eur. J. Neurosci. 5:1993;933-943.
9. Gupta S., Campbell D., Derijard B., Davis R.J. Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
10. Hagmeyer B.M., König H., Herr I., Offringa R., Zantema A., Eb van der A.J., Herrlich P., Angel P. Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun. EMBO J. 12:1993;3559-3572.
11. Hai, Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA. 88:1991;3720-3724.
12. Hai, Liu F., Coukos W.J., Green M.R. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3:1989;2083-2090.
13. Herdegen T., Brecht S., Mayer W., Leah J.D., Kummer W., Bravo R., Zimmermann M. Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy. J. Neurosci. 13:1993;4130-4145.
14. Herdegen T., Kovary K., Buhl A., Bravo R., Zimmermann M., Gass P. Basal expression of the inducible transcription factors c-Jun, JunB, JunD, c-Fos, FosB and Krox-24 in the adult rat brain. J. Comp. Neurol. 354:1995;39-56.
15. Herdegen T., Blume A., Buschmann T., Georgakopoulos E., Winter C., Beer J., Schmid W., Hsieh T.F., Zimmermann M., Gass P. Expression of ATF-2, SRF and CREB in the adult rat brain following generalized seizures, nerve fibers transection and UV-irradiation. Neuroscience. 81:1997;199-212.
16. Herdegen T., Skene P., Bähr M. The c-Jun protein-transcriptional mediator of neuronal servival and death. Trends Neurosci. 21:1997;227-231.
17. Herr I., van Dam H., Angel P. Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis. 15:1994;1105-1113.
18. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-jun activation domain. Genes Dev. 7:1993;2135-2148.
19. Hummler E., Coll T.J., Blendy J.A., Ganss R., Aguzzi A., Schmid W., Beermann F., Schütz G. Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc. Natl. Acad. Sci. USA. 91:1994;5647-5651.
20. Kallunki T., Deng T., Hibi M., Karin M. c-jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 87:1996;1-20.
21. Livingstone C., Patel G., Jones N. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14:1994;1785-1797.
22. Kara C.J., Liou H.C., Glimcher L.H. A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol. Cell. Biol. 10:1990;1347-1357.
23. Macgregor P.F., Abate C., Curran T. Direct cloning of leucine zipper proteins: jun binds cooperatively to the CRE with CRE-BP1. Oncogene. 5:1990;451-458.
24. Maekawa T., Sakura H., Kanai-Ishii C., Sudo T., Yoshimura T., Fujisawa J., Yoshida M., Ishii S. Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain. EMBO J. 8:1989;2023-2028.
25. Morooka H., Bonventre J.V., Pombo C.M., Kyriakis J.M., Force T. Ischemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from the c-jun promoter. J. Biol. Chem. 270:1995;30084-30092.
26. Nagase T., Sudo T., Maekawa T., Yoshimura T., Fujisawa J., Yoshida M., Ishii S. Promoter region of the CRE-BP1 encoding the transcriptional regulator binding to the cyclic AMP response element. J. Biol. Chem. 265:1990;17300-17306.
27. Nedivi E., Hevroni D., Naot D., Israeli D., Citri Y. Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature. 363:1993;718-721.
28. Reimold A.M., Grusby M.J., Kosaras B., Fries J.W.U., Mori R., Maniwa S., Clauss I.M., Collins T., Sidman R.L., Glimcher M.J., Glimcher L.H. Chondrodysplasia and neurological abnormalities in ATF-2 deficient mice. Nature. 379:1996;262-264.
29. Robinson G.A. Changes in the expression of transcription factors ATF-2 and Fra-2 after axotomy and during regeneration in rat retinal ganglion cells. Mol. Brain Res. 41:1996;57-64.
30. Schöbitz B., de Kloet E.R., Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44:1994;397-432.
31. Takeda J., Maekawa T., Sudo T., Seino Y., Imura H., Seito N., Tanaka C., Ishii S. Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response element in central nervous system, regenerating liver and human tumors. Oncogene. 6:1991;1009-1014.
32. van Dam H., Duyndam M., Rottier R., Bosch A., de Vries-Smits L., Herrlich P., Zantema A., Angel P., van der Eb A.J. Heterodimer formation of c-Jun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12:1993;479-487.
33. van Dam H., Wilhelm D., Herr I., Steffen A., Herrlich P., Angel P. ATF-2 is preferentially activated by stress-activated protein kinase to mediate c-jun induction in response to genotoxic agents. EMBO J. 14:1995;798-1811.
34. Zea Longa E., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.